A randomized phase II study of GDC-0980 versus everolimus in metastatic renal cell carcinoma (mRCC) patients (pts) after VEGF-targeted therapy (VEGF-TT) Meeting Abstract
| Authors: | Powles, T.; Oudard, S.; Escudier, B. J.; Brown, J. E.; Hawkins, R. E.; Castellano, D. E.; Ravaud, A.; Staehler, M. D.; Rini, B. I.; Lin, W.; O'Keeffe, B.; Byrtek, M.; Lackner, M.; Spoerke, J. M.; Ware, J. A.; Zhu, R.; Motzer, R. J. |
| Abstract Title: | A randomized phase II study of GDC-0980 versus everolimus in metastatic renal cell carcinoma (mRCC) patients (pts) after VEGF-targeted therapy (VEGF-TT) |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613203330 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.4525 |
| Notes: | Meeting Abstract: 4525 -- Source: Wos |
